Kim Janda - 27 Dec 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
Director
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
Issuer symbol
SRNEQ
Transactions as of
27 Dec 2021
Net transactions value
-$5,640
Form type
4
Filing time
27 Dec 2021, 18:34:40 UTC
Previous filing
28 Sep 2021
Next filing
06 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRNEQ Common Stock Options Exercise $12,000 +3,000 +100% $4.00 6,000 27 Dec 2021 Direct F1
transaction SRNEQ Common Stock Sale $17,640 -3,000 -50% $5.88 3,000 27 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Non-qualified stock option Options Exercise $0 -3,000 -100% $0.000000* 0 27 Dec 2021 Common Stock 3,000 $4.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.